MicroRNA Therapeutics: the Next Magic Bullet?

MicroRNAs are short noncoding 18-25 nucleotide long RNA which bind and inhibit mRNA. Currently, there are over 1000 known human microRNAs, and microRNAs control over 50% of mammalian protein coding genes. MicroRNAs can be overexpressed or repressed in different diseases and inhibition or replacement of microRNAs is a promising area of study for therapeutics. Here we review the current knowledge of microRNA therapy, and discuss ways in which they can be utilized. We also discuss different methods of delivery of miRNA, and current clinical trials of microRNA-based therapies for disease. Finally we discuss the current limitations in the field, and how these limitations are being overcome.

[1]  T. Tuschl,et al.  The Human DiGeorge Syndrome Critical Region Gene 8 and Its D. melanogaster Homolog Are Required for miRNA Biogenesis , 2004, Current Biology.

[2]  F. Slack,et al.  Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  D. Bonci,et al.  Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of Chronic Lymphocytic Leukemia , 2011, Genes and Immunity.

[4]  P. Pandolfi,et al.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010, Nature.

[5]  Bo Yu,et al.  MicroRNA delivery by cationic lipoplexes for lung cancer therapy. , 2011, Molecular pharmaceutics.

[6]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[7]  Anil K Sood,et al.  Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. , 2005, Cancer research.

[8]  M. Ozen,et al.  Designing a gold nanoparticle‐based nanocarrier for microRNA transfection into the prostate and breast cancer cells , 2014, The journal of gene medicine.

[9]  V. Adam,et al.  Magnetic nanoparticles and targeted drug delivering. , 2010, Pharmacological research.

[10]  S. Kauppinen,et al.  Treatment of HCV infection by targeting microRNA. , 2013, The New England journal of medicine.

[11]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[12]  R. Hartmann,et al.  MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. , 2011, Cancer research.

[13]  L. J. Lee,et al.  Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer , 2013, Molecular therapy. Nucleic acids.

[14]  K. Chowdhury,et al.  The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy , 2012, Nature Communications.

[15]  Tao Gong,et al.  Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Qihong Huang,et al.  Small-molecule inhibitors of microrna miR-21 function. , 2008, Angewandte Chemie.

[17]  Shubiao Zhang,et al.  Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[18]  S. Kauppinen,et al.  Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.

[19]  J. D’hooge,et al.  Long‐Term miR‐669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice , 2013, Journal of the American Heart Association.

[20]  Guiliang Tang,et al.  The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 , 2008, The Journal of Neuroscience.

[21]  Douglas D Young,et al.  Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. , 2010, Journal of the American Chemical Society.

[22]  Joshua T. Mendell,et al.  Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice , 2011, Molecular Cancer Therapeutics.

[23]  Phillip A Sharp,et al.  MicroRNA sponges: progress and possibilities. , 2010, RNA.

[24]  Daniel A. Balazs,et al.  Liposomes for Use in Gene Delivery , 2010, Journal of drug delivery.

[25]  B. Monia,et al.  Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals , 2006, Nucleic acids research.

[26]  Zhongchan Sun,et al.  In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model. , 2014, Nanoscale.

[27]  S. Mitragotri,et al.  Topical delivery of siRNA into skin using SPACE-peptide carriers. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[28]  S. Kauppinen,et al.  Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice , 2011, EMBO molecular medicine.

[29]  L. Buscail,et al.  Targeting miR-21 for the therapy of pancreatic cancer. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  Ye Ding,et al.  Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition , 2012, PloS one.

[31]  C. Kang,et al.  A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo. , 2014, Oncology reports.

[32]  H. Rehrauer,et al.  Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. , 2011, Blood.

[33]  P. Doevendans,et al.  Inhibition of miR-25 Improves Cardiac Contractility in the Failing Heart , 2014, Nature.

[34]  P. Choyke,et al.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.

[35]  Jørgen Kjems,et al.  miRNA‐dependent gene silencing involving Ago2‐mediated cleavage of a circular antisense RNA , 2011, The EMBO journal.

[36]  P. Boekstegers,et al.  Cardiac AAV9-S100A1 Gene Therapy Rescues Post-Ischemic Heart Failure in a Preclinical Large Animal Model , 2011, Science Translational Medicine.

[37]  Ferdinando Di Cunto,et al.  Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs , 2011, Cell.

[38]  Kuan-Teh Jeang,et al.  Identification of Small Molecules That Suppress MicroRNA Function and Reverse Tumorigenesis* , 2010, The Journal of Biological Chemistry.

[39]  Christopher J. Cheng,et al.  Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma , 2012, Proceedings of the National Academy of Sciences.

[40]  R. Hui,et al.  MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1 , 2014, Journal of cellular and molecular medicine.

[41]  B. Liu,et al.  Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  Catherine L Jopling,et al.  Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. , 2008, Cell host & microbe.

[43]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[44]  Alexander Deiters,et al.  High-Throughput Luciferase Reporter Assay for Small-Molecule Inhibitors of MicroRNA Function , 2012, Journal of biomolecular screening.

[45]  Robert Persson,et al.  A locked nucleic acid oligonucleotide targeting microRNA 122 is well-tolerated in cynomolgus monkeys. , 2012, Nucleic acid therapeutics.

[46]  Z. Paroo,et al.  A small molecule enhances RNA interference and promotes microRNA processing , 2008, Nature Biotechnology.

[47]  M. Behlke,et al.  Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier , 2013, Molecular therapy. Nucleic acids.

[48]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[49]  A. Pasquinelli,et al.  A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA , 2001, Science.

[50]  A. Bouchie.  First microRNA mimic enters clinic , 2013, Nature Biotechnology.

[51]  Sun-Mi Park,et al.  The role of let-7 in cell differentiation and cancer. , 2010, Endocrine-related cancer.

[52]  M. Behlke,et al.  A Direct Comparison of Anti-microRNA Oligonucleotide Potency , 2010, Pharmaceutical Research.

[53]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[54]  Lei Han,et al.  AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression. , 2013, Cancer research.

[55]  H. Sweeney,et al.  Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. , 2008, Human gene therapy.

[56]  Souvik Maiti,et al.  The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor. , 2012, Angewandte Chemie.

[57]  J. Kjems,et al.  Natural RNA circles function as efficient microRNA sponges , 2013, Nature.

[58]  K. Kelnar,et al.  Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. , 2010, Cancer research.

[59]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[60]  D. Bartel,et al.  Expanded identification and characterization of mammalian circular RNAs , 2014, Genome Biology.

[61]  A. Deiters,et al.  Cellular microRNA sensors based on luciferase reporters. , 2014, Methods in molecular biology.

[62]  Ying Feng,et al.  Supplemental Data P53-mediated Activation of Mirna34 Candidate Tumor-suppressor Genes , 2022 .

[63]  A. Bradley,et al.  Identification of mammalian microRNA host genes and transcription units. , 2004, Genome research.